Skip to main content
رجوع
PGNY logo

Progyny, Inc.

جودة البيانات: 100%
PGNY
NASDAQ Healthcare Medical - Healthcare Information Services
KWD 17.75
▼ KWD 0.30 (-1.66%)
القيمة السوقية: 1.45B
نطاق اليوم
KWD 17.20 KWD 18.36
نطاق 52 أسبوعًا
KWD 16.76 KWD 28.75
حجم التداول
1,088,337
متوسط 50 يوم / 200 يوم
KWD 21.58 / KWD 22.49
الإغلاق السابق
KWD 18.05

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 24.8 0.2
P/B 2.8 3.0
ROE % 12.5 3.6
Net Margin % 4.5 3.8
Rev Growth 5Y % 26.7 9.7
D/E 0.1 0.2

السعر المستهدف للمحللين

Hold
KWD 30.80 +73.5%
Low: KWD 28.00 High: KWD 35.00
مكرر الربحية المستقبلي
15.18
ربحية السهم المستقبلية
KWD 1.17
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.38B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 1.64
KWD 1.60 – KWD 1.68
 1.68B 1
FY2029 KWD 1.85
KWD 1.80 – KWD 1.90
 1.69B 1
FY2028 KWD 1.73
KWD 1.39 – KWD 1.96
 1.59B 3

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-26 KWD 0.38 KWD 0.48 +26.3%
2025-11-06 KWD 0.39 KWD 0.45 +15.4%
2025-08-07 KWD 0.44 KWD 0.48 +9.1%
2025-05-08 KWD 0.45 KWD 0.48 +6.7%
2025-02-27 KWD 0.37 KWD 0.42 +13.5%
2024-11-12 KWD 0.37 KWD 0.40 +8.1%
2024-08-06 KWD 0.36 KWD 0.43 +19.4%
2024-05-09 KWD 0.14 KWD 0.39 +178.6%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 26.67% annually over 5 years — strong growth
ROE of 12.48% — decent returns on equity
Debt/Equity of 0.05 — conservative balance sheet
Generating 191.78M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 16.27%
Cash machine — converts 327.72% of earnings into free cash flow

النمو

Revenue Growth (5Y)
26.67%
Revenue (1Y)10.40%
Earnings (1Y)7.70%
FCF Growth (3Y)1.77%

الجودة

Return on Equity
12.48%
ROIC11.84%
Net Margin4.54%
Op. Margin6.62%

الأمان

Debt / Equity
0.05
Current Ratio2.73
Interest Coverage0.00

التقييم

P/E Ratio
24.84
Forward P/E15.18
P/B Ratio2.82
EV/EBITDA16.01
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 10.40% Revenue Growth (3Y) 8.80%
Earnings Growth (1Y) 7.70% Earnings Growth (3Y) -2.88%
Revenue Growth (5Y) 26.67% Earnings Growth (5Y) -2.88%
Profitability
Revenue (TTM) 1.29B Net Income (TTM) 58.52M
ROE 12.48% ROA 7.88%
Gross Margin 23.63% Operating Margin 6.62%
Net Margin 4.54% Free Cash Flow (TTM) 191.78M
ROIC 11.84% FCF Growth (3Y) 1.77%
Safety
Debt / Equity 0.05 Current Ratio 2.73
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 24.84 Forward P/E 15.18
P/B Ratio 2.82 P/S Ratio 1.13
PEG Ratio 2.45 Forward PEG N/A
EV/EBITDA 16.01 Fwd EV/EBITDA 9.72
Forward P/S 1.06 Fwd Earnings Yield 6.59%
FCF Yield 13.19%
Market Cap 1.45B Enterprise Value 1.37B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.29B 1.17B 1.09B 786.91M 500.62M
Net Income 58.52M 54.34M 62.04M 30.36M 65.77M
EPS (Diluted) 0.65 0.57 0.62 0.30 0.66
Gross Profit 304.48M 253.36M 238.80M 167.33M 112.14M
Operating Income 85.28M 67.46M 62.18M 23.34M 32.34M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 742.44M 607.10M 756.62M 542.99M 358.07M
Total Liabilities 226.39M 185.04M 203.19M 166.02M 106.24M
Shareholders' Equity 516.04M 422.06M 553.43M 376.97M 251.82M
Total Debt 24.00M 19.27M 19.39M 7.71M 8.65M
Cash & Equivalents 112.24M 162.31M 97.30M 120.08M 91.41M
Current Assets 551.78M 472.72M 640.41M 433.86M 258.54M
Current Liabilities 202.39M 168.63M 185.95M 159.54M 98.82M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#536 of 1049
44

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026